Valvulopathy

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Angel Pharmaceuticals
Angel PharmaceuticalsChina - Zhejiang
1 program
Polyurethane expandable valve stent implantN/A1 trial
Active Trials
NCT05289622UnknownEst. Feb 2023

Trial Timeline

Clinical trial activity over time

2022
2023
2024
2025
2026
Angel PharmaceuticalsPolyurethane expandable valve stent implant

Clinical Trials (1)

NCT05289622Angel PharmaceuticalsPolyurethane expandable valve stent implant

Stent Implantation of Polyurethane Expandable Valve, by Catheter, in Patients With Pulmonary Valve Dysfunction

Start: Oct 2022Est. completion: Feb 2023
N/AUnknown

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space